Hui Huang

Dr. Hui Huang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2015 in Scientific Reports
Verified
Journal Article
Open access
CCChenchen Cui
Chenchen Cui
YSYujie Song
Yujie Song
JLJun Liu
Jun Liu
HGHengtao Ge
Hengtao Ge
QLQian Li
Qian Li
YZYong Zhang
Yong Zhang
β-Lactoglobulin (BLG) is a major goat’s milk allergen that is absent in human milk. Engineered endonucleases, including transcription activator-like effector nucleases (TALENs) and zinc-finger nucleases, enable targeted genetic modification in livestock. In this study, TALEN-mediated gene knockout followed by gene knock-in were used to generate BLG knockout goats as mammary gland bioreactors for large-scale production of human lactoferrin (hLF). We introduced precise genetic modifications in the goat genome at frequencies of approximately 13.6% and 6.09% for the first and second sequential targeting, respectively, by using targeting vectors that underwent TALEN-induced homologous recombination (HR). Analysis of milk from the cloned goats revealed large-scale hLF expression or/and decreased BLG levels in milk from heterozygous goats as well as the absence of BLG in milk from homozygous goats. Furthermore, the TALEN-mediated targeting events in somatic cells can be transmitted through the germline after SCNT. Our result suggests that gene targeting via TALEN-induced HR may expedite the production of genetically engineered livestock for agriculture and biomedicine.

1 August 2017 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
WHWoo Hyun Han
Woo Hyun Han
JGJonathan Gotzmann
Jonathan Gotzmann
SKSharee Kuny
Sharee Kuny
HHHui Huang
Hui Huang
Catherine ChanCatherine Chan
Catherine Chan
YSYves Sauvé
Yves Sauvé
Purpose: To characterize retinal mitochondrial respiration associated with type 2 diabetes (T2D) progression in a cone-rich diurnal rodent, the Nile rat (genus Arvicanthis, species niloticus). Methods: Nile rats were fed a standard rodent diet that resulted in rising glucose levels from 6 months. Age-matched control animals were fed a high-fiber diet that prevented diabetes up to 18 months. The functional status of specific retinal mitochondrial components and mitochondrial outer membrane integrity were studied by using high-resolution respirometry. Ocular complications were documented with funduscopy, electroretinography (ERG), and trypsin digestion of retinal vasculature. Results: Mitochondrial functional changes were detected during hyperinsulinemia with maintained normoglycemia (2 months), corresponding to stage 1 of human T2D. Our data showed increased contribution of mitochondrial respiration through the NADH pathway relative to maximal oxidative phosphorylation capacity, with simultaneous electron entry into NADH (Complex I and related dehydrogenases) and succinate (Complex II) pathways. These compensatory events coincided with compromised mitochondrial outer membrane integrity. The first clinical sign of retinopathy (pericyte loss) was only detected at 12 months (after 6 months of sustained hyperglycemia) alongside a common ocular complication of diabetes, cataractogenesis. Further prolongation of hyperglycemia (from 12 to 18 months) led to capillary degeneration and delayed photopic ERG oscillatory potentials. Conclusions: Oxidative phosphorylation compensatory changes in the retina can be detected as early as 2 months, before development of hyperglycemia, and are associated with reduced mitochondrial outer membrane integrity.

1 June 2016 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
KYKaiyuan Yang
Kaiyuan Yang
JGJonathan Gotzmann
Jonathan Gotzmann
SKSharee Kuny
Sharee Kuny
HHHui Huang
Hui Huang
YSYves Sauvé
Yves Sauvé
CCCatherine B Chan
Catherine B Chan
We compared the evolution of insulin resistance, hyperglycemia and pancreatic β-cell dysfunction in the Nile rat (Arvicanthis niloticus), a diurnal rodent model of spontaneous type 2 diabetes, when maintained on regular laboratory chow, versus a high fibre diet. Chow fed Nile rats already displayed symptoms characteristic of insulin resistance at 2 months (increased fat/lean mass ratio and hyperinsulinemia). Hyperglycemia was first detected at 6 months, with increased incidence at 12 months. By this age, pancreatic islet structure was disrupted (increased α-cell area), insulin secretion was impaired (reduced insulin secretion and content) in isolated islets, insulin processing was compromised (accumulation of proinsulin and C-peptide inside islets) and endoplasmic reticulum chaperone protein ERp44, was up-regulated in insulin producing β-cells. In contrast, high fibre fed Nile rats had normoglycemia with compensatory increase in β-cell mass resulting in maintained pancreatic function. Fasting glucose levels were predicted by the α/β-cell ratios. Our results show that Nile rats fed Chow recapitulate the five stages of progression of type 2 diabetes as occurs in human disease, including insulin resistant hyperglycemia and pancreatic islet β-cell dysfunction associated with endoplasmic reticulum stress. Modification of diet alone permits long-term β-cell compensation and prevents type 2 diabetes.

Verified
Journal Article
Open access
PDF file
HHHui Huang
Hui Huang
BLBradi R. Lorenz
Bradi R. Lorenz
PZPaula Horn Zelmanovitz
Paula Horn Zelmanovitz
Catherine ChanCatherine Chan
Catherine Chan
Prediabetes is a high-risk condition for type 2 diabetes (T2D). Pancreatic β-cells adapt to impaired glucose regulation in prediabetes by increasing insulin secretion and β-cell mass expansion. In people with prediabetes, metformin has been shown to prevent prediabetes conversion to diabetes. However, emerging evidence indicates that metformin has negative effects on β-cell function and survival. Our previous study established the Nile rat (NR) as a model for prediabetes, recapitulating characteristics of human β-cell compensation in function and mass expansion. In this study, we investigated the action of metformin on β-cells in vivo and in vitro. A 7-week metformin treatment improved glucose tolerance by reducing hepatic glucose output and enhancing insulin secretion. Although high-dose metformin inhibited β-cell glucose-stimulated insulin secretion in vitro, stimulation of β-cell insulin secretion was preserved in metformin-treated NRs via an indirect mechanism. Moreover, β-cells in NRs receiving metformin exhibited increased endoplasmic reticulum (ER) chaperones and alleviated apoptotic unfold protein response (UPR) without changes in the expression of cell identity genes. Additionally, metformin did not suppress β-cell mass compensation or proliferation. Taken together, despite the conflicting role indicated by in vitro studies, administration of metformin does not exert a negative effect on β-cell function or cell mass and, instead, early metformin treatment may help protect β-cells from exhaustion and decompensation.

1 March 2014 in Biotechnology and Bioprocess Engineering
Verified
Journal Article
Closed access
PDF file
GHGuangdong Hu
Guangdong Hu
JWJing Wang
Jing Wang
HHHui Huang
Hui Huang
FQFusheng Quan
Fusheng Quan
JKJian Kang
Jian Kang
YZYong Zhang
Yong Zhang

1 August 2014
Verified
Journal Article
Closed access
HHHui Huang
Hui Huang
GHGuangdong Hu
Guangdong Hu
JKJian Kang
Jian Kang
SQSuzhu Qing
Suzhu Qing
YZYong Zhang
Yong Zhang